FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. The paper describes the use of a double-stranded RNA preparation obtained from the killer yeast Saccharomyces cerevisiae or its pharmaceutically acceptable salts for a new purpose, namely for the treatment and/or prevention of coronavirus infection caused by SARS-CoV-2.
EFFECT: invention provides improved therapeutic and prophylactic activity of a dsRNA preparation obtained from killer yeast strains Saccharomyces cerevisiae in relation to infection caused by SARS-CoV-2.
6 cl, 2 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| A NEW KILLER YEAST STRAIN SACCHAROMYCES CEREVISIAE | 2022 |
|
RU2790685C1 |
| PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
| METHOD FOR OBTAINING TOTAL RNA FROM BIOMASS OF SACCHAROMYCES CEREVISIAE YEAST CELLS | 2022 |
|
RU2781832C1 |
| METHOD FOR PRODUCING DOUBLE-STRANDED RIBONUCLEIC ACID FROM SACCHAROMYCES CEREVISIAE YEAST CELLS | 2022 |
|
RU2781833C1 |
| INTERFERON INDUCTOR SUPPOSITORIES | 2005 |
|
RU2328272C2 |
| LIPOSOMAL INTERFERON INDUCER | 2004 |
|
RU2306936C2 |
| INTERFERON INDUCTOR "FLORENTA" AND A METHOD FOR THE PREVENTION AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2783947C1 |
| METHOD FOR PRODUCING BIOLOGICALLY ACTIVE COMPONENTS FROM YEAST CELLS SACCHAROMYCES CEREVISIAE AND A THERAPEUTIC AGENT BASED THEREON | 2018 |
|
RU2722731C2 |
| METHOD OF PRODUCTION OF DOUBLE-STRANDED RIBONUCLEIC ACID (dsRNA) FROM CELLS OF YEAST Saccharomyces cerevisiae | 2014 |
|
RU2558256C1 |
| METHOD FOR PRODUCTION OF DOUBLE-HELICAL RIBONUCLEIC ACID | 2003 |
|
RU2302464C2 |
